The heat shock transcription factor 1 as a potential new therapeutic target in multiple myelomaTanja Heimberger(Comprehensive Cancer Center Mainfranken), Manik Chatterjee(University of Würzburg)British Journal of HaematologyDecember 18, 201210.1111/bjh.12164Cited by 65SaveCiteExport RISWatch citationsRelated PapersIn the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp130/STAT3 pathway|Blood|2002|100HDAC2-dependent remodeling of KCa2.2 (KCNN2) and KCa2.3 (KCNN3) K+ channels in atrial fibrillation with concomitant heart failure|Life Sciences|2020|20Epigenetic regulation of cardiac electrophysiology in atrial fibrillation: HDAC2 determines action potential duration and suppresses NRSF in cardiomyocytes|Basic Research in Cardiology|2021|17